Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: Perceptive Advisors' Joe Edelman discusses with Roivant Sciences CEO Matt Gline how biotech investing has changed over his extensive career, and his philosophy on running an investment firm. Watch the full episode:

BiotechTV's profile picture

BiotechTV

11,751 subscribers

16,768 Aufrufe โ€ข vor 1 Monat โ€ขvia X (Twitter)

LIVE

Anya Rossiโ€ข Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfรผgbar

Kommentare vom Original-Post werden hier angezeigt

ร„hnliche Videos

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:
6:11

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

BiotechTV

11,639 Aufrufe โ€ข vor 3 Monaten

๐“๐จ๐ฆ๐จ๐ซ๐ซ๐จ๐ฐ: Tune in tomorrow morning for a new episode of Off-Target Effects with Roivant Sciences CEO Matt Gline. Matt's next guest needs no introduction and is one of the most experienced investors in biotech, Perceptive Advisors' CEO and Portfolio Manager Joe Edelman!
0:48

๐“๐จ๐ฆ๐จ๐ซ๐ซ๐จ๐ฐ: Tune in tomorrow morning for a new episode of Off-Target Effects with Roivant Sciences CEO Matt Gline. Matt's next guest needs no introduction and is one of the most experienced investors in biotech, Perceptive Advisors' CEO and Portfolio Manager Joe Edelman!

BiotechTV

20,583 Aufrufe โ€ข vor 1 Monat

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: John Maraganore ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฌ๐Ÿ‡ท๐Ÿ‡บ๐Ÿ‡ฆ has been a champion of innovation throughout his career. He and Matt Gline discuss the road to success at Alnylam Pharmaceuticals, today's environment, and keeping the U.S. on top. Watch the episode:
0:33

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: John Maraganore ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ฌ๐Ÿ‡ท๐Ÿ‡บ๐Ÿ‡ฆ has been a champion of innovation throughout his career. He and Matt Gline discuss the road to success at Alnylam Pharmaceuticals, today's environment, and keeping the U.S. on top. Watch the episode:

BiotechTV

18,386 Aufrufe โ€ข vor 3 Monaten

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:
3:49

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:

BiotechTV

25,829 Aufrufe โ€ข vor 6 Monaten

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: Matt Gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector. Full video:
7:13

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: Matt Gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector. Full video:

BiotechTV

20,748 Aufrufe โ€ข vor 1 Jahr

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy. See the whole interview here:
1:05

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy. See the whole interview here:

BiotechTV

16,344 Aufrufe โ€ข vor 6 Monaten

๐๐ž๐ฐ ๐’๐ก๐จ๐ฐ ๐€๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ: Today BiotechTV is excited to announce our newest regular show - Off-Target Effects with Matt Gline. Matt will share his perspective on news, and interview other biotech leaders. Visit the show's dedicated page:
2:56

๐๐ž๐ฐ ๐’๐ก๐จ๐ฐ ๐€๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ: Today BiotechTV is excited to announce our newest regular show - Off-Target Effects with Matt Gline. Matt will share his perspective on news, and interview other biotech leaders. Visit the show's dedicated page:

BiotechTV

37,136 Aufrufe โ€ข vor 1 Jahr

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:
4:30

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:

BiotechTV

13,777 Aufrufe โ€ข vor 8 Monaten

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:
6:09

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:

BiotechTV

14,405 Aufrufe โ€ข vor 1 Jahr

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:
8:50

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:

BiotechTV

13,446 Aufrufe โ€ข vor 1 Monat

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ฎ๐ž๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Americas Senior Analyst Graig Suvannavejh shares his take on the difficult biotech environment and discusses upcoming clinical trail catalysts for companies he covers. $AXSM $VIGL $VSTM $CRVS $HRMY Full video:
6:08

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ฎ๐ž๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Americas Senior Analyst Graig Suvannavejh shares his take on the difficult biotech environment and discusses upcoming clinical trail catalysts for companies he covers. $AXSM $VIGL $VSTM $CRVS $HRMY Full video:

BiotechTV

13,455 Aufrufe โ€ข vor 1 Jahr

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Meet some of the incredible Female Biotech CEO leaders of the Biotech CEO Sisterhood!
1:37

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Meet some of the incredible Female Biotech CEO leaders of the Biotech CEO Sisterhood!

BiotechTV

12,276 Aufrufe โ€ข vor 6 Monaten

๐‡๐’๐๐‚ ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: Jon Norris has published his full-year venture healthcare report today. The report is full of biotech sector insights like raises, exits, and deals. Download the report: #sponsored
2:02

๐‡๐’๐๐‚ ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: Jon Norris has published his full-year venture healthcare report today. The report is full of biotech sector insights like raises, exits, and deals. Download the report: #sponsored

BiotechTV

18,404 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:
3:01

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 Aufrufe โ€ข vor 1 Monat

In this episode of The Money Mindset, we sit down with Pankaj Tibrewal of Ikigai Asset Manager Pankaj Tibrewal He is one of India's best known midcap fund managers and someone with over 2 decades of investing experience ! We spoke about the current market set up , how to identify value stocks , his investment philosophy , outlook on gold and lots more โœจ Full episode out now โœจ ๐Ÿ‘‡
1:33

In this episode of The Money Mindset, we sit down with Pankaj Tibrewal of Ikigai Asset Manager Pankaj Tibrewal He is one of India's best known midcap fund managers and someone with over 2 decades of investing experience ! We spoke about the current market set up , how to identify value stocks , his investment philosophy , outlook on gold and lots more โœจ Full episode out now โœจ ๐Ÿ‘‡

Sonia Shenoy

35,517 Aufrufe โ€ข vor 11 Monaten

In this episode of #TheSecretaryKennedyPodcast, Mike Tyson opens up about his childhood, growing up on ultra-processed food, and how mentorship and discipline changed his life. Watch the full episode now:
0:53

In this episode of #TheSecretaryKennedyPodcast, Mike Tyson opens up about his childhood, growing up on ultra-processed food, and how mentorship and discipline changed his life. Watch the full episode now:

Secretary Kennedy

41,352 Aufrufe โ€ข vor 3 Monaten

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:
4:48

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:

BiotechTV

17,128 Aufrufe โ€ข vor 7 Monaten

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:
3:27

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:

BiotechTV

29,397 Aufrufe โ€ข vor 5 Monaten

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: Legend Biotech CEO Ying Huang on moving Carvykti into earlier settings, potential future competition, beyond BCMA, and more. #ASH24 $LEGN Full video:
0:48

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: Legend Biotech CEO Ying Huang on moving Carvykti into earlier settings, potential future competition, beyond BCMA, and more. #ASH24 $LEGN Full video:

BiotechTV

16,621 Aufrufe โ€ข vor 1 Jahr

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:
7:30

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:

BiotechTV

11,800 Aufrufe โ€ข vor 1 Jahr